NCT07365982

Brief Summary

This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

January 9, 2026

Last Update Submit

January 16, 2026

Conditions

Keywords

SchizophreniaPsychoeducationMotivational InterviewingKnowledge LevelHope

Outcome Measures

Primary Outcomes (1)

  • Schizophrenia Knowledge Level

    Change in schizophrenia-related knowledge level assessed using the Schizophrenia Knowledge Level Scale. The scale consists of multiple-choice items assessing knowledge about schizophrenia, with total scores ranging from 0 to 25. Higher scores indicate greater knowledge about schizophrenia.

    Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).

Secondary Outcomes (1)

  • Schizophrenia Hope Level

    Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).

Study Arms (2)

Psychoeducation-Based Motivational Interviewing

EXPERIMENTAL

Participants received a psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, in addition to routine community mental health services.

Behavioral: Psychoeducation-Based Motivational Interviewing

Control Group - Routine Community Mental Health Services

NO INTERVENTION

Participants received routine community mental health center services only, without any additional psychosocial or motivational interviewing intervention.

Interventions

A structured psychoeducation-based motivational interviewing program delivered in weekly sessions lasting approximately 60-90 minutes, consisting of one preparatory session followed by five main sessions.

Psychoeducation-Based Motivational Interviewing

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteered to participate in the study and provided informed consent
  • Aged between 18 and 65 years
  • Literate
  • Diagnosed with schizophrenia according to DSM-5 diagnostic criteria
  • In remission phase (not in an acute exacerbation period)

You may not qualify if:

  • Presence of severe intellectual disability as documented in hospital records
  • Diagnosis of dementia and/or other organic mental disorders
  • Currently in an acute exacerbation phase
  • Discontinuation of intervention sessions or failure to complete assessment forms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zeytinburnu Community Mental Health Center (TRSM)

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Ceren Aycanoğlu, Assoc. Prof. Dr.

    Okan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was blinded to group allocation during the pre-test, post-test, and follow-up assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to either an intervention group or a control group and followed in parallel throughout the study period.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator ,Graduate Student in Psychiatric Nursing

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 26, 2026

Study Start

April 21, 2025

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared, as the study is conducted as part of a master's thesis and the data are collected solely for academic purposes. All data are kept confidential in accordance with ethical approval and institutional regulations.

Locations